Sulzer Medica Entering Peripheral Stent Market Via IntraTherapeutics

Sulzer Medica's $145 mil. purchase of privately held IntraTherapeutics provides the firm an entry into the $300 mil. peripheral stent market and complements Sulzer's heart valve and vascular graft businesses.